Market Overview

Top 4 Stocks In The Diagnostic Substances Industry With The Highest Profit Margin

Share:
Related TRIB
Top 4 Small-Cap Stocks In The Diversified Communication Services Industry With The Highest EPS
Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest EPS
Trinity Biotech's (TRIB) CEO Ronan O'Caoimh on Q2 2015 Results - Earnings Call Transcript (Seeking Alpha)
Related VIVO
Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest Operating Margin
Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest EPS

Below are the top diagnostic substances stocks on the NYSE and the NASDAQ in terms of profit margin.

The trailing-twelve-month profit margin at Trinity Biotech plc (NASDAQ: TRIB) is 20.71%. Trinity Biotech's ROA for the same period is 5.89%.

The trailing-twelve-month profit margin at Meridian Bioscience (NASDAQ: VIVO) is 19.23%. Meridian Bioscience's revenue for the same period is $173.54 million.

The trailing-twelve-month profit margin at IDEXX Laboratories (NASDAQ: IDXX) is 13.50%. IDEXX Laboratories' PEG ratio is 1.91.

The trailing-twelve-month profit margin at Neogen (NASDAQ: NEOG) is 12.35%. Neogen's ROE for the same period is 10.90%.

Posted-In: Diagnostic Substances Industry Highest Profit MarginTrading Ideas

 

Related Articles (IDXX + NEOG)

Get Benzinga's Newsletters